Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of Dr. Zhen Bouman Chen. Built upon her interdisciplinary training in medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on noncoding RNAs and
-
Sciences. The Marcucci laboratory studies the pathogenesis of acute myeloid leukemia (AML) and development of new treatments for AML based on these discoveries. We seek an independent and highly motivated
-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on noncoding RNAs and endothelial stress response. Her team integrates innovative high
-
motivated and talented individual to fill a postdoctoral position in the field of gamma-herpesvirus structural biology. The goal of the postdoctoral candidate will be to elucidate the mechanisms of gamma
-
translated landmark scientific discoveries into treatments that have improved the lives of diabetic patients around the world. TRCT focuses on stem cell biology and development, translational and clinical
-
in handling bio-hazardous materials. Your qualifications should include: Bachelor’s degree in biology, biochemistry, chemistry or related field, with 2 years of post-degree research experience, or 1
-
Research Associate II, you'll have the opportunity to work on cutting-edge projects that contribute to the advancement of medical science and have a direct impact on patient outcomes. As a successful
-
motivated and talented individual to fill a postdoctoral position in the field of gamma-herpesvirus structural biology. The goal of the postdoctoral candidate will be to elucidate the mechanisms of gamma
-
Sciences. The Marcucci laboratory studies the pathogenesis of acute myeloid leukemia (AML) and development of new treatments for AML based on these discoveries. We seek an independent and highly motivated
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and